We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Comprehensive Analysis of Next-Generation Biologics

Comprehensive Analysis of Next-Generation Biologics content piece image

With more elucidation of disease pathology, the development of next generation protein therapeutics has become the trend of protein therapeutics development. Unfortunately, these next-generation biologics (NGBs), such as fusion proteins, exhibit additional levels of complexity beyond regular monoclonal antibody therapeutics. New methods, techniques and efficient data analysis software in liquid chromatography-tandem mass spectrometry (LC-MS/MS) hold the key for accelerating the development of NGBs and increasing their availability.

Attend this webinar to: 

  • Discover how protein impurity in intact mass analysis can be easily identified with Biologics Explorer with its powerful visualization tool
  • Learn about the novel capabilities of the SCIEX ZenoTOF 7600 System with a patented ion trap and how it can be applied to the acquisition of intact mass and peptide-level data
  • Explore how to perform intact mass analysis for heavily glycosylated proteins
  • Learn how to get accurate site-specific N-linked and O-linked glycan profiling
A picture of Zoe Zhang, PhD
Zoe Zhang, PhD
Manager, Biopharma Applications, SCIEX